PA
TXG icon

Profund Advisors’s 10x Genomics TXG Stock Holding History

Profund Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,663
Closed -$389K – 1165
2022
Q4 		$389K Buy
10,663
+300
+3% +$9.81K 0.03% 514
2022
Q3 		$295K Sell
10,363
-369
-3% -$14.1K 0.02% 598
2022
Q2 		$486K Sell
10,732
-678
-6% -$35.2K 0.03% 421
2022
Q1 		$868K Sell
11,410
-1,181
-9% -$103K 0.04% 357
2021
Q4 		$1.88M Sell
12,591
-2,100
-14% -$322K 0.06% 216
2021
Q3 		$2.14M Buy
14,691
+2,032
+16% +$349K 0.07% 218
2021
Q2 		$2.48M Sell
12,659
-228
-2% -$41.3K 0.08% 193
2021
Q1 		$2.33M Sell
12,887
-997
-7% -$172K 0.09% 183
2020
Q4 		$1.97M Buy
13,884
+2,620
+23% +$380K 0.09% 197
2020
Q3 		$1.4M Buy
11,264
+8,696
+339% +$913K 0.07% 223
2020
Q2 		$229K Buy
+2,568
New +$200K 0.01% 750

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Profund Advisors's TXG Position: Q1 2023 in Review

Profund Advisors sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 10,663 shares — an estimated $389K sold.

Profund Advisors first reported a position in TXG in Q2 2020 and held it in 11 quarters. The position peaked at $2.48M in Q2 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • Profund Advisors reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
  • Profund Advisors sold 10,663 10x Genomics shares in Q1 2023, an estimated $389K.
  • Profund Advisors first reported a position in 10x Genomics in Q2 2020 and held it in 11 quarters.
  • Profund Advisors's 10x Genomics position peaked at $2.48M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.